276 related articles for article (PubMed ID: 31733165)
1. Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow-up.
Alvarez CS; Graubard BI; Thistle JE; Petrick JL; McGlynn KA
Hepatology; 2020 Aug; 72(2):430-440. PubMed ID: 31733165
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States.
Kim D; Wijarnpreecha K; Sandhu KK; Cholankeril G; Ahmed A
Liver Int; 2021 Aug; 41(8):1832-1840. PubMed ID: 33641244
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States.
Golabi P; Paik J; Reddy R; Bugianesi E; Trimble G; Younossi ZM
BMC Gastroenterol; 2019 Apr; 19(1):56. PubMed ID: 30991959
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic Fatty Liver Disease Is Independently Associated With Higher All-Cause and Cause-Specific Mortality.
de Avila L; Henry L; Paik JM; Ijaz N; Weinstein AA; Younossi ZM
Clin Gastroenterol Hepatol; 2023 Sep; 21(10):2588-2596.e3. PubMed ID: 36646233
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM
Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
[TBL] [Abstract][Full Text] [Related]
6. The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United States.
Wijarnpreecha K; Scribani M; Kim D; Kim WR
Liver Int; 2019 Jul; 39(7):1202-1206. PubMed ID: 30697898
[TBL] [Abstract][Full Text] [Related]
7. The impact of modifiable risk factors on the long-term outcomes of non-alcoholic fatty liver disease.
Paik JM; Deshpande R; Golabi P; Younossi I; Henry L; Younossi ZM
Aliment Pharmacol Ther; 2020 Jan; 51(2):291-304. PubMed ID: 31782543
[TBL] [Abstract][Full Text] [Related]
8. Depression in nonalcoholic fatty liver disease and all-cause/cause-specific mortality.
Kim D; Manikat R; Shaikh A; Cholankeril G; Ahmed A
Eur J Clin Invest; 2024 Jan; 54(1):e14087. PubMed ID: 37638383
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men.
Hwang YC; Ahn HY; Park SW; Park CY
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1131-1137.e5. PubMed ID: 29158157
[TBL] [Abstract][Full Text] [Related]
10. Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD).
Golabi P; Otgonsuren M; de Avila L; Sayiner M; Rafiq N; Younossi ZM
Medicine (Baltimore); 2018 Mar; 97(13):e0214. PubMed ID: 29595666
[TBL] [Abstract][Full Text] [Related]
11. Diet quality and its association with nonalcoholic fatty liver disease and all-cause and cause-specific mortality.
Yoo ER; Kim D; Vazquez-Montesino LM; Escober JA; Li AA; Tighe SP; Fernandes CT; Cholankeril G; Ahmed A
Liver Int; 2020 Apr; 40(4):815-824. PubMed ID: 31910319
[TBL] [Abstract][Full Text] [Related]
12. The systemic immune-inflammation index was non-linear associated with all-cause mortality in individuals with nonalcoholic fatty liver disease.
Zhao E; Cheng Y; Yu C; Li H; Fan X
Ann Med; 2023 Dec; 55(1):2197652. PubMed ID: 37052341
[TBL] [Abstract][Full Text] [Related]
13. Liver fat scores predict liver disease mortality in the United States population.
Unalp-Arida A; Ruhl CE
Aliment Pharmacol Ther; 2018 Nov; 48(9):1003-1016. PubMed ID: 30295948
[TBL] [Abstract][Full Text] [Related]
14. Gallstone Disease and Its Association With Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality.
Konyn P; Alshuwaykh O; Dennis BB; Cholankeril G; Ahmed A; Kim D
Clin Gastroenterol Hepatol; 2023 Apr; 21(4):940-948.e2. PubMed ID: 35643414
[TBL] [Abstract][Full Text] [Related]
15. Selenium intake in relation to all-cause and cardiovascular mortality in individuals with nonalcoholic fatty liver disease: A nationwide study in nutrition.
Dong X; Deng Y; Chen G
PLoS One; 2024; 19(5):e0303140. PubMed ID: 38768120
[TBL] [Abstract][Full Text] [Related]
16. Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study.
Hajifathalian K; Torabi Sagvand B; McCullough AJ
Hepatology; 2019 Aug; 70(2):511-521. PubMed ID: 30125379
[TBL] [Abstract][Full Text] [Related]
17. Association Between Diabetes Mellitus and All-Cause and Cardiovascular Mortality Among Individuals With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease.
Wu W; Xiang J; Chen X
Front Endocrinol (Lausanne); 2021; 12():773342. PubMed ID: 34992579
[TBL] [Abstract][Full Text] [Related]
18. Total Bilirubin Levels in Nonalcoholic Fatty Liver Disease and All- cause and Cause-specific Mortality in US Adults.
Moss K; Dennis BB; Naji L; Ahmed A; Kim D
J Gastrointestin Liver Dis; 2023 Sep; 32(3):323-331. PubMed ID: 37774224
[TBL] [Abstract][Full Text] [Related]
19. Physical Activity, Measured Objectively, Is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease.
Kim D; Murag S; Cholankeril G; Cheung A; Harrison SA; Younossi ZM; Ahmed A
Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1240-1247.e5. PubMed ID: 32683103
[TBL] [Abstract][Full Text] [Related]
20. Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease.
Golabi P; Fukui N; Paik J; Sayiner M; Mishra A; Younossi ZM
Hepatol Commun; 2019 Aug; 3(8):1050-1060. PubMed ID: 31388626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
